Overview The CDC has recommended that all Americans aged 6 months and older get the updated COVID-19 vaccine when it becomes available this fall. This advice comes as a new wave of COVID infections spreads across the country. Key Points Recommendation Date: June 28, 2024 Target Group: Everyone over 6 months of age Reason: To provide a timely boost in immunity as the virus evolves Why Get the Updated Vaccine? Evolving Virus: The virus continues to mutate, which can decrease the effectiveness of previous vaccinations. …
Overview State officials in New Hampshire are investigating a possible measles exposure after an international traveler tested positive for the disease. The traveler visited several locations in Hanover, New Hampshire, before testing positive upon returning home. Key Details Traveler’s Locations in Hanover: Dartmouth College campus Hanover Inn Bus from Hanover to Logan Airport in Boston Public Health Alert: The Massachusetts Department of Public Health warned about the case on Saturday. Important Information Potential Exposure: People who flew from Boston to Amsterdam on June 22, between …
Introduction Recent tests by the FDA found bird flu (H5N1) in half of the raw milk samples from dairy farms. However, the tests also confirmed that flash pasteurization effectively kills the virus, making the milk safe to drink. Key Findings Tested Samples: The FDA tested 275 raw milk samples from four states with H5N1-positive herds. Results: Half of the samples had traces of the virus, and a quarter of these were infectious. Safety of Pasteurized Milk: The infected raw milk was intended for pasteurization, not …
Overview Eli Lilly, a major pharmaceutical company, is having a fantastic year. The company’s stock has increased by over 50% in the first half of the year. This growth is mainly due to the success of their diabetes and obesity medications, Mounjaro and Zepbound. However, there’s more happening at Eli Lilly that investors should know about, especially regarding their Alzheimer’s treatment. Positive News for Alzheimer’s Treatment One of Eli Lilly’s main goals is to get FDA approval for donanemab, their drug candidate for Alzheimer’s disease. …
Introduction A recent large-scale study by the National Cancer Institute found no link between daily multivitamin use and a lower risk of death in healthy adults. The research, which analyzed data from almost 400,000 people over more than 20 years, was published in JAMA Network Open on June 26, 2024. Study Overview Participants: Nearly 400,000 healthy adults in the U.S. Duration: More than 20 years Study Title: “Multivitamin Use and Mortality Risk in 3 Prospective US Cohorts” Publication Date: June 26, 2024 Source: National Cancer …